The Short QT Syndrome Panel examines 6 genes associated with hereditary Short QT syndrome (SQTS).
Who is this test for?
Patients with a personal and/or family history suggestive of SQTS. Short QT syndrome is defined by a shortened QT interval on an electrocardiogram (ECG). Red flags for SQTS can include, but are not limited to, atrial fibrillation, ventricular tachycardia, ventricular fibrillation, syncope, cardiac arrest, or sudden cardiac death. SQTS is very rare.
What are the potential benefits for my patient?
Patients identified with SQTS can benefit from increased surveillance and preventative steps to better manage their risks. Medical intervention can include beta blockers, implantable devices, and lifestyle changes. Also, your patient’s family members can be tested to help define their risk. If a pathogenic variant is identified in your patient, close relatives (children, siblings, parents) could have as high as a 50% risk to also be at increased risk. In some cases, screening should begin in childhood.